Identification of a Rare EGFR T790I Mutation in Lung Adenocarcinoma Sensitive to Osimertinib

Identification of a Rare EGFR T790I Mutation in Lung Adenocarcinoma Sensitive to Osimertinib

Estimated glomerular filtration rate (EGFR)-sensitive mutations are extremely important for targeted treatment strategies in lung cancer. Osimertinib can effectively inhibit the activity of EGFR-sensitive mutations, including the T790M mutation. However, the efficiency of osimertinib for rare mutati...

Full description

Bibliographic Details
Main Authors: Yu Wang, Songtao Liu, Alei Feng, Huan Luo, Jinwei Hu, Kai Wang, Wei Dong
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Oncology
Subjects:
lung adenocarcinoma (AC)
T790I
osimertinib
EGFR
target therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.727312/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.727312/full

Similar Items